Effect of Momordica charantia Leaf Extract on Female Fertility and Foetal Well-Being in Sprague-Dawley Rats
http://www.doi.org/10.26538/tjnpr/v6i10.27
Keywords:
Momordica charantia,, Pre-mating treatment,, Female infertility, Female infertility,, Foetal measurementAbstract
Infertility is a public health issue and women are often blamed for the childlessness of a couple. Solution is sort, sometimes from traditional medicines usually lacking scientific proof of efficacy. This research was aimed at investigating the effect of Momordica charantia leaf extract on female fertility and the well-being of the conceived fetuses. Momordica charantia has been utilized traditionally to treat various ailments with reported biological activities. There is however a dearth of knowledge on the effects of its leaf on female fertility and foetal well-being. Ethanol extract of M. charantia leaf (McL) was administered orally to cyclic Sprague-Dawley (S-D) rats at 100 mg/kg in pre-mating treatment for 14-17 days. Fertility index increased by 20%, number of implantation sites and live fetuses also increased. Foetal weight and crown- rump length in McL group were significantly (p < 0.05) higher than control with no physical malformations observed. This study suggests that pre-mating administration of Momordica charantia leaf extract to Sprague-Dawley rats confers pro-fertility and pro-implantation activities without foetal death or intrauterine growth restrictions at the dose administered.
References
McLeod C and Ponesse J. Infertility and moral luck: The Politics of women blaming themselves for infertility. Int J Fem Approaches to Bioeth 2008; 1(1):126-144.
World Health Organisation (WHO). Infertility [Fact Sheet]. https://www.who.int /news-room/fact-sheets/detail/infertility, 2020.
Safarzadeh A, Ghaedniajahromi M, Ghaedniajahromi M, Rigi F, Massori N. Intra uterine fetal death and some related factors: A silent tragedy in southeastern Iran. J Pain Relief. 2014; 3:129. DOI: 10.4172/2167-0846.1000129.
Inhorn MC and Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 2015; 21(4):411–426.
Agarwal A, Finelli R, Selvam MKP, Leisegana K, Majzoub A, Tadros N, Ko E, Parekh N, Henkel R, Durairajanayagam D, Colpi GM, Cho C,Sallam HN, Park HU, Saleh R, Micic S, Ambar RF, Zini A, Tremellen K, Alvarez JG, Palani A, Arafa M, Gava MM, Jindal S, Amar E, Kopa Z, Moein M, Busetto GM, Sengupta P, Kavoussi P, Maldonado I, Fikri J, Borges Jr. E, Martinez M, Bojovic D, Rajmil O, Aydos K, Parekattil S, Marmar JL, Sefrioui O, JungwirthA, Pena MGR, Cordts EB, Elbardisi H, Mostafa T, Sabbaghian M, Gilani MAS, Morimoto Y, Alves MG, Spasic A, Kenic U. Ramsay J, Akande EO, Oumeziane A, Dozortsev D, Chung E, Bell EG, Allegra A, Tanos V, Fiadjoe M, Gurgan T, Abou-Abdallah M, Al-Rumaih H, Oborna I, Arab H, Esteves S, Amer M, Kadioglu A, Yuzko O, Korsak V and Shah R. A global survey of reproductive specialists to determine the clinical utility of oxidative stress testing and antioxidant use in male infertility. World J of Mens Health. 2021; 39(3):470- 488.
Fainberg J and Kashanian JA. Recent advances in understanding and managing male infertility. F1000Res 2019; 8:670.
Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S and Stevens GA. National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLOS Medicine 2012; 9:1-12.
Umeora OU, Mbazor JO and Okpere EE. Tubal factor infertility in Benin City Nigeria- Sociodemographics of patients and aetiopathogenic factor. Trop Doct. 2007; 37(2):92-94.
Lawrenz B, Coughlan C, Melado L and Fatemi HM. Ethical and sociocultural differences causing infertility are poorly understood-insight from the Arabian perspective. J Assist Reprod and Genet. 2019; 36: 661-665.
Olootu EE, Ambali AA, Banjo TA. A review of female infertility; important etiological factors and management. J Microbiol Biotechnol Res. 2012; 2(3):379-385.
Wachtel-Galor S and Benzie IFF. Herbal Medicine, an introduction to its history, usage, regulation, current trends, and research needs. In: Benzie IFF, Wachtel-Galor S, (Eds.). Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton: CRC Press/Taylor and Francis Group, 2011:1-10.
Owolabi MA, Ogah CO, Adebayo KO, Soremi EM. Evaluation of antidiabetic potential and biochemical parameters of aqueous pod extract of Moringa oleifera in alloxan diabetic rats. Trop J Nat Prod Res. 2020; 4(2):50-57.
Mahomoodally MF. Review Article: Traditional Medicines in Africa: An Appraisal of Ten Potent African Medicinal Plants. Evid-based Complement Altern Med. 2013; 8:317- 459.
Mbemya GT, Vieira LA, Canafistula FG, Pessoa ODL, Rodrigues APR. Report on in vivo and in vitro contribution of medicinal plants to improve the female reproductive function. Reprod. Clim. 2017; 32(2):109-119.
Muhammad BY and Awaisu A. The need for enhancement of research, development, and commercialization of natural medicinal products in Nigeria: Lessons from the Malaysian experience. Afr J Tradit Complement Altern Med. 2008; 5(2):120-130.
De-Campos OC, Layole MP, Iheagwam FN, Rotimi SO, Chinedu SN. Effect of aqueous extract of Momordica charantia on survival, locomotive behavior and antioxidant status of Drosophila melanogaster. Trop J Nat Prod Res. 2021; 5(1):178-181.
Sofowora A. Medicinal Plants and Traditional Medicine in Africa. Ibadan: Spectrum Books, 2006.
Anilakumar KR, Kumar GP, Ilaiyaraja N. Nutritional, Pharmacological and Medicinal Properties of Momordica charantia. Int J Nut Food Sci. 2015; 4(1):75-83.
Mishra A, Gautam S, Pal S, Mishra A, Rawat AK, Maurya R, Rivastava AK. Effect of Momordica charantia fruits on streptozotocin-induced diabetes mellitus and its associated complications. Int J Pharm and Pharm Sci 2015; 7(3):356- 363.
Perumal V, Khoo WC, Abdul-Hamid A, Ismail A, Saari K, Murugesu S, Abas F. Evaluation of antidiabetic properties of Momordica charantia in streptozotocin-induced diabetic rats using metabolomics approach. Int Food Res J. 2015; 22(3):1298-1306.
Xu X, Shan B, Liao CH, Xie JH, Wen PW, Shi JY. Anti- diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice. Int J Biol Macromol. 2015; 81:538-543.
Poovitha S and Parani M. In vitro and in vivo α-amylase and α- glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complement and Altern Med 2016; 16(S1):185 DOI: 10.1186/s12906-016-1085-1.
Fan X, He L, Meng Y, Li G, Li L, Meng Y. α-MMC and MAP30, two ribosome-inactivating proteins extracted from Momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells. Mol Med Rep. 2015; 11(5):3553-3558.
Dia VP and Krishnan HB. BG-4, a novel anticancer peptide from bitter gourd (Momordica charantia), promotes apoptosis in human colon cancer cells. Sci Rep 2016; 6:33532.
Lin H, Zhi-Guo Z, Cong-Hui H, Yan Z, Qing L, Bo J, Hou- Guang H, Jun- Jie Z and Pei-Ying Z. Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells. Minerva Urol and Nefrol. 2016; 68(3):275-281.
Chan DW, Yung MMH, Chan Y, Xuan Y, Yang H, Xu D, Zhan J, Chan KKL, Ng T and Ngan HYS. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis. Pharmacol Res. 2020; 161:105157.
Pongthanapisith V, Ikuta K, Puthavathana P, Leelamanit W. Antiviral protein of Momordica charantia L. Inhibits different subtypes of influenza A. Evid-based Complement and Alternat Med. 2013; (1): 729081 DOI: 10.1155/2013/729081.
Angamuthu D, Purushothaman I, Kothandan S and Swaminathan R. Antiviral study on Punica granatum L., Momordica charantia L., Andrographis paniculata Nees, and Melia azedarach L., to human herpes virus-3. Eur J Integr Med. 2019; 28:98-108.
Singh SK, Singh S, Singh R. Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia. J Ovarian Res 2021; 14(126) DOI: 10.1186/s13048-021-00872-3.
Osonuga AO, Osonuga I, Osonuga A. Evaluation of oral administration of aqueous leaf extract of Momordica charantia on fertility hormones of adult male Wister rats. Glob J Pharmacol. 2014; 8(2):150-153.
Luangpirom A, Kourchampa W, Somsapt P. Effect of Momordica charantia Linn. leaf and fruit juice on fertility in male mice. Int J Phytomedicine. 2015; 7(2):199-204.
Amah CI, Yama OE, Noronha CC. Infecund evaluation of cyclic female sprague-dawley rats: an aftermath treatment with Momordica charantia seed extract. Middle East Fertil Soc J. 2012; 17:37-41.
Sheeja EJ, Ajeet P, Papiya B, Shilpi S. Antifertility activity of Momordica charantia Descourt pulp and seed hydroalcoholic extract. J Appl Pharm. 2012; 3(4):682-696.
Ugwah-Oguejiofor CJ, Bello SO, Okolo RU, Etuk EU, Ugwah MO and Igbikwe VU. Ficus platyphylla promotes fertility in female Rattus norvegicus wister strain: A preliminary study. Reprod Biol Endocrinol. 2011; 9:145-150.
Raji Y, Morakinyo AO, Oloyo AK, Akinsomisoye OS, Kunle-Alabi OT, Esegbue-Peters PRC and Awobajo FO. Impact of chloroform extract of Carica papaya seed on oestrus cycle and fertility in female albino rats. J Med Sci. 2005; 5:337-343.
Watcho P, Ngadjui E, Alango NP, Benoit NT, kamanyi A. Reproductive effect of ficus aspeifolia (Moraceae) in female rats. Afr Health Sci. 2009; 9:49-53.
Wise LD, Spence S, Saldutti LP, Kerr JS. Assessment of Female and Male Fertility in Sprague–Dawley Rats Administered Vorinostat, a Histone Deacetylase Inhibitor. Birth Defects Res (Part B) 2008; 83:19-26.
Tafessel G, Mekonnen Y, Makonnen E. Antifertiliy effect of aqueous and ethanol extracts of the leaves and roots of Asparagus africanus in rats. Afr Health Sci. 2006; 6:81-85.
Bakare RI, Magbagbeola OA, Akinwande AI, Okunowo OW. Nutritional and chemical evaluation of Momordica charantia. J Med Plant Res. 2010; 4(21):2189-2193.
Unterscheider J, O’Donoghue K, Daly S, Geary MP, Kennelly MM, McAuliffe FM, Hunter A, Morrison JJ, Burke G, Dicker P, Tully EC and Malone FD. Fetal growth restriction and the risk of perinatal mortality-case studies from the multicenter PORTO study. BMC Pregnancy Childbirth 2014; 14(63). DOI: 10.1186/1471-2393-14-63.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
